Stock ScreenerStock IdeasZen Ratings + Top Analysts
Stocks With a Zen Rating of A + Top Analyst consensus of Strong Buy + Large Upside in Target Price: Nov 18, 2025
The 2 best sources of winning stocks is the Zen Ratings and our analysis of Top Analysts from Wall Street. Now we have combined them together in a best of both worlds approach to find stocks with the best upside potential.

Zen Rating: A
Upside/Downside: Large Upside
Top Analysts Consensus: Strong Buy
Ticker
Company
Exchange
Industry
Zen Rating
Market Cap
Price
1d %
EBITDA
P/E
D/E
Country
DD Score
DXCM
DEXCOM INC
NASDAQ
Medical Devices
A$22.81B$58.490.74%$1.22B31.79x1.75
United States
47
PTC
PTC INC
NASDAQ
Software - Application
A$20.87B$174.21-3.01%$885.58M40.89x0.77
United States
46
TPR
TAPESTRY INC
NYSE
Luxury Goods
A$20.82B$101.740.33%$598.20M74.81x14.93
United States
36
USFD
US FOODS HOLDING CORP
NYSE
Food Distribution
A$15.88B$71.24-0.70%$1.50B29.08x2.14
United States
48
NBIX
NEUROCRINE BIOSCIENCES INC
NASDAQ
Drug Manufacturers - Specialty & Generic
A$14.31B$143.56-0.90%$679.20M33.31x0.42
United States
52
PRIM
PRIMORIS SERVICES CORP
NYSE
Engineering & Construction
A$6.33B$117.15-0.75%$513.21M22.84x1.86
United States
54
MOG.A
MOOG INC
NYSE
Aerospace & Defense
A$6.21B$195.97-2.71%$436.71M29.42x1.26
United States
31
SGHC
SUPER GROUP (SGHC) LTD
NYSE
Gambling
A$6.11B$12.08-1.39%N/A24.26x0.60
Guernsey
32
GTES
GATES INDUSTRIAL CORP PLC
NYSE
Specialty Industrial Machinery
A$5.52B$21.39-3.08%$672.10M23.25x1.02
United States
37
MIRM
MIRUM PHARMACEUTICALS INC
NASDAQ
Biotechnology
A$3.71B$72.211.08%-$592.00k-84.95x1.69
United States
26
TPC
TUTOR PERINI CORP
NYSE
Engineering & Construction
A$3.10B$58.76-0.54%$108.27M-108.81x3.28
United States
28
FOLD
AMICUS THERAPEUTICS INC
NASDAQ
Biotechnology
A$2.91B$9.42-0.63%$59.28M-235.50x2.77
United States
23
SUPN
SUPERNUS PHARMACEUTICALS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
A$2.59B$45.090.20%$64.66M-136.64x0.35
United States
28
SPNT
SIRIUSPOINT LTD
NYSE
Insurance - Reinsurance
A$2.30B$19.73-2.95%$339.10M11.89x4.64
Bermuda
28
HCI
HCI GROUP INC
NYSE
Insurance - Property & Casualty
A$2.25B$173.75-3.47%$301.16M10.07x1.82
United States
50
DBD
DIEBOLD NIXDORF INC
NYSE
Software - Application
A$2.21B$61.48-5.55%$303.10M44.23x2.36
United States
41
IHS
IHS HOLDING LTD
NYSE
Telecom Services
A$2.10B$6.250.16%N/A4.46x-34.21
United Kingdom
30
PGY
PAGAYA TECHNOLOGIES LTD
NASDAQ
Software - Infrastructure
A$1.84B$22.30-6.77%-$155.79M-8.14x2.03
Israel
21
BLBD
BLUE BIRD CORP
NASDAQ
Auto Manufacturers
A$1.59B$50.00-2.29%$175.74M13.77x1.59
United States
46
BCRX
BIOCRYST PHARMACEUTICALS INC
NASDAQ
Biotechnology
A$1.48B$7.03-0.71%$83.87M-140.60x-2.15
United States
17
CRTO
CRITEO SA
NASDAQ
Advertising Agencies
A$1.05B$19.91-4.14%$219.28M6.38x0.79
France
51
NRDS
NERDWALLET INC
NASDAQ
Internet Content & Information
A$996.17M$13.70-2.00%$98.00M14.12x0.23
United States
47
ANAB
ANAPTYSBIO INC
NASDAQ
Biotechnology
A$962.73M$34.772.81%-$82.14M-12.69x-13.00
United States
15
ORGO
ORGANOGENESIS HOLDINGS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
A$760.20M$5.99-1.80%$18.04M-49.92x0.49
United States
21
BWMN
BOWMAN CONSULTING GROUP LTD
NASDAQ
Engineering & Construction
A$583.22M$33.57-2.89%$38.00M34.26x0.95
United States
53
AKBA
AKEBIA THERAPEUTICS INC
NASDAQ
Biotechnology
A$467.04M$1.765.39%$25.70M-22.00x7.76
United States
25
OPRX
OPTIMIZERX CORP
NASDAQ
Health Information Services
A$282.97M$15.18-1.81%$11.65MN/A0.39
United States
29
EGHT
8X8 INC
NASDAQ
Software - Application
A$259.26M$1.87-4.10%$51.06M-46.75x4.04
United States
16
ELMD
ELECTROMED INC
NYSEMKT
Medical Devices
A$205.43M$24.63-2.53%$12.05M25.39x0.20
United States
57
CXDO
CREXENDO INC
NASDAQ
Telecom Services
A$198.22M$6.45-5.29%$7.94M43.00x0.24
United States
44
INFU
INFUSYSTEM HOLDINGS INC
NYSEMKT
Medical Instruments & Supplies
A$189.53M$9.32-2.00%$24.16M35.85x0.78
United States
45

Upgrade to Premium to View More

Use the proven Zen Ratings quant model to find stocks with high potential to beat the market. Stocks Zen-Rated "A" have beaten the market by +32.52% annually. Learn More

Already have access to Premium? Sign In
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.